Hepatitis D Virus Infection of Mice Expressing Human Sodium Taurocholate Co-transporting Polypeptide

PLoS Pathogens

Volumn 11, Issue 4, 2015, Pages

  He, Wenhui ^a,b   Ren, Bijie ^b   Mao, Fengfeng ^b   Jing, Zhiyi ^b   Li, Yunfei ^b   Liu, Yang ^b   Peng, Bo ^b   Yan, Huan ^b   Qi, Yonghe ^b,c   Sun, Yinyan ^b   Guo, Ju Tao ^d   Sui, Jianhua ^b   Wang, Fengchao ^b   Li, Wenhui ^a,b  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES   (China)

^c BEIJING NORMAL UNIVERSITY   (China)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CATECHOLAMINE; CORTICOSTERONE; NORADRENALIN; ALPHA BETA INTERFERON RECEPTOR; COTRANSPORTER; HYBRID PROTEIN; IFNAR1 PROTEIN, MOUSE; MONOCLONAL ANTIBODY; ORGANIC ANION TRANSPORTER; SODIUM-BILE ACID COTRANSPORTER; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ADRENERGIC SYSTEM; ADULT; ARTICLE; CRANIOTOMY; DEAFFERENTATION; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; IMMOBILIZATION STRESS; MALE; NONHUMAN; RADIOIMMUNOASSAY; RAT; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL CULTURE; CROSS BREEDING; DRUG EFFECTS; FEMALE; GENETICS; GERMFREE ANIMAL; HEPATITIS D; HEPATITIS DELTA VIRUS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; KNOCKOUT MOUSE; LIVER CELL; METABOLISM; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE; VIROLOGY;

ANIMALIA; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; MUS;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; CELLS, CULTURED; CROSSES, GENETIC; FEMALE; HEPATITIS D; HEPATITIS DELTA VIRUS; HEPATOCYTES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; ORGANIC ANION TRANSPORTERS, SODIUM-DEPENDENT; RECEPTOR, INTERFERON ALPHA-BETA; RECOMBINANT FUSION PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS; SYMPORTERS; VIRAL ENVELOPE PROTEINS;

EID: 84929485973     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004840     Document Type: Article

References (45)

1. Lai MM, (1995) The molecular biology of hepatitis delta virus. Annu Rev Biochem 64: 259–286. 7574482
2. Taylor JM, (2006) Hepatitis delta virus. Virology 344: 71–76. 16364738
3. Ciancio A, Rizzetto M, (2014) Chronic hepatitis D at a standstill: where do we go from here? Nat Rev Gastroenterol Hepatol 11: 68–71. doi: 10.1038/nrgastro.2013.164 24019153
4. Wedemeyer H, Manns MP, (2010) Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nat Rev Gastroenterol Hepatol 7: 31–40. doi: 10.1038/nrgastro.2009.205 20051970
5. Hagenbuch B, Meier PJ, (1994) Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter. J Clin Invest 93: 1326–1331. 8132774
6. Yan H, Zhong G, Xu G, He W, Jing Z, et al. (2012) Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife 1: e00049. doi: 10.7554/eLife.00049 23150796
7. Yan H, Peng B, He W, Zhong G, Qi Y, et al. (2013) Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptide. J Virol 87: 7977–7991. doi: 10.1128/JVI.03540-12 23678176
8. Ni Y, Lempp FA, Mehrle S, Nkongolo S, Kaufman C, et al. (2013) Hepatitis B and D Viruses Exploit Sodium Taurocholate Co-transporting Polypeptide for Species-specific Entry into Hepatocytes. Gastroenterology 146: 1070–1083. doi: 10.1053/j.gastro.2013.12.024 24361467
9. Li H, Zhuang Q, Wang Y, Zhang T, Zhao J, et al. (2014) HBV life cycle is restricted in mouse hepatocytes expressing human NTCP. Cell Mol Immunol 11: 175–183. doi: 10.1038/cmi.2013.66 24509445
10. Sureau C, Salisse J, (2013) A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus a-determinant. Hepatology 57: 985–994. doi: 10.1002/hep.26125 23161433
11. Chen PJ, Kalpana G, Goldberg J, Mason W, Werner B, et al. (1986) Structure and replication of the genome of the hepatitis delta virus. Proc Natl Acad Sci U S A 83: 8774–8778. 2430299
12. Custer RP, Bosma GC, Bosma MJ, (1985) Severe combined immunodeficiency (SCID) in the mouse. Pathology, reconstitution, neoplasms. Am J Pathol 120: 464–477. 2412448
13. Christianson SW, Greiner DL, Schweitzer IB, Gott B, Beamer GL, et al. (1996) Role of natural killer cells on engraftment of human lymphoid cells and on metastasis of human T-lymphoblastoid leukemia cells in C57BL/6J-scid mice and in C57BL/6J-scid bg mice. Cell Immunol 171: 186–199. 8806787
14. Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, et al. (1995) Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 154: 180–191. 7995938
15. Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, et al. (1994) Functional role of type I and type II interferons in antiviral defense. Science 264: 1918–1921. 8009221
16. Stetson DB, Medzhitov R, (2006) Type I interferons in host defense. Immunity 25: 373–381. 16979569
17. Sen GC, (2001) Viruses and interferons. Annu Rev Microbiol 55: 255–281. 11544356
18. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, et al. (2011) A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472: 481–485. doi: 10.1038/nature09907 21478870
19. Liu SY, Sanchez DJ, Aliyari R, Lu S, Cheng G, (2012) Systematic identification of type I and type II interferon-induced antiviral factors. Proc Natl Acad Sci U S A 109: 4239–4244. doi: 10.1073/pnas.1114981109 22371602
20. Chang J, Sigal LJ, Lerro A, Taylor J, (2001) Replication of the human hepatitis delta virus genome Is initiated in mouse hepatocytes following intravenous injection of naked DNA or RNA sequences. J Virol 75: 3469–3473. 11238873
21. George CX, Samuel CE, (1999) Human RNA-specific adenosine deaminase ADAR1 transcripts possess alternative exon 1 structures that initiate from different promoters, one constitutively active and the other interferon inducible. Proc Natl Acad Sci U S A 96: 4621–4626. 10200312
22. Casey JL, (2012) Control of ADAR1 editing of hepatitis delta virus RNAs. Curr Top Microbiol Immunol 353: 123–143. doi: 10.1007/82_2011_146 21732238
23. Bonino F, Heermann KH, Rizzetto M, Gerlich WH, (1986) Hepatitis delta virus: protein composition of delta antigen and its hepatitis B virus-derived envelope. J Virol 58: 945–950. 3701932
24. Guidotti LG, Matzke B, Schaller H, Chisari FV, (1995) High-level hepatitis B virus replication in transgenic mice. J Virol 69: 6158–6169. 7666518
25. Raney AK, Eggers CM, Kline EF, Guidotti LG, Pontoglio M, et al. (2001) Nuclear covalently closed circular viral genomic DNA in the liver of hepatocyte nuclear factor 1 alpha-null hepatitis B virus transgenic mice. J Virol 75: 2900–2911. 11222715
26. Stieger B, (2011) The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation. Handb Exp Pharmacol: 205–259. doi: 10.1007/978-3-642-14541-4_5 21103971
27. Meier A, Mehrle S, Weiss TS, Mier W, Urban S, (2012) The myristoylated preS1-domain of the hepatitis B virus L-protein mediates specific binding todifferentiated hepatocytes. Hepatology 58: 31–42.
28. Schieck A, Schulze A, Gahler C, Muller T, Haberkorn U, et al. (2013) Hepatitis B virus hepatotropism is mediated by specific receptor recognition in the liver and not restricted to susceptible hosts. Hepatology 58: 43–53. doi: 10.1002/hep.26211 23292963
29. Giersch K, Helbig M, Volz T, Allweiss L, Mancke LV, et al. (2013) Persistent hepatitis D virus mono-infection in humanized mice is efficiently converted by hepatitis B virus to a productive co-infection. J Hepatol 60: 538–544. doi: 10.1016/j.jhep.2013.11.010 24280293
30. Lutgehetmann M, Mancke LV, Volz T, Helbig M, Allweiss L, et al. (2012) Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation. Hepatology 55: 685–694. doi: 10.1002/hep.24758 22031488
31. Levy O, (2007) Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 7: 379–390. 17457344
32. Dakic A, Shao QX, D'Amico A, O'Keeffe M, Chen WF, et al. (2004) Development of the dendritic cell system during mouse ontogeny. J Immunol 172: 1018–1027. 14707075
33. Sigel MM, (1952) Influence of age on susceptibility to virus infections with particular reference to laboratory animals. Annu Rev Microbiol 6: 247–280. 13008397
34. Tregoning JS, Yamaguchi Y, Wang B, Mihm D, Harker JA, et al. (2010) Genetic susceptibility to the delayed sequelae of neonatal respiratory syncytial virus infection is MHC dependent. J Immunol 185: 5384–5391. doi: 10.4049/jimmunol.1001594 20921522
35. Sellers RS, (2012) The gene or not the gene—that is the question: understanding the genetically engineered mouse phenotype. Vet Pathol 49: 5–15. doi: 10.1177/0300985811421324 21971987
36. Publicover J, Gaggar A, Nishimura S, Van Horn CM, Goodsell A, et al. (2013) Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B. J Clin Invest 123: 3728–3739. doi: 10.1172/JCI68182 23925290
37. Publicover J, Goodsell A, Nishimura S, Vilarinho S, Wang ZE, et al. (2011) IL-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis B. J Clin Invest 121: 1154–1162. doi: 10.1172/JCI44198 21393863
38. Ponzetto A, Cote PJ, Popper H, Hoyer BH, London WT, et al. (1984) Transmission of the hepatitis B virus-associated delta agent to the eastern woodchuck. Proc Natl Acad Sci U S A 81: 2208–2212. 6585793
39. Guilhot S, Huang SN, Xia YP, La Monica N, Lai MM, et al. (1994) Expression of the hepatitis delta virus large and small antigens in transgenic mice. J Virol 68: 1052–1058. 8289334
40. Polo JM, Jeng KS, Lim B, Govindarajan S, Hofman F, et al. (1995) Transgenic mice support replication of hepatitis delta virus RNA in multiple tissues, particularly in skeletal muscle. J Virol 69: 4880–4887. 7609056
41. Ponzetto A, Hoyer BH, Popper H, Engle R, Purcell RH, et al. (1987) Titration of the infectivity of hepatitis D virus in chimpanzees. J Infect Dis 155: 72–78. 3794405
42. Netter HJ, Kajino K, Taylor JM, (1993) Experimental transmission of human hepatitis delta virus to the laboratory mouse. J Virol 67: 3357–3362. 8497056
43. Hartwig D, Schutte C, Warnecke J, Dorn I, Hennig H, et al. (2006) The large form of ADAR 1 is responsible for enhanced hepatitis delta virus RNA editing in interferon-alpha-stimulated host cells. J Viral Hepat 13: 150–157. 16475990
44. Chao M, Hsieh SY, Taylor J, (1990) Role of two forms of hepatitis delta virus antigen: evidence for a mechanism of self-limiting genome replication. J Virol 64: 5066–5069. 2398535
45. Casey JL, Gerin JL, (1995) Hepatitis D virus RNA editing: specific modification of adenosine in the antigenomic RNA. J Virol 69: 7593–7600. 7494266